https://doi.org/10.1038/srep38937
X
Xu Hu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
211
Papers
2.8K
Citations
29
h-index
58
i10-index
Xu Hu is an academic researcher from Liaoning University. The author has contributed to research in topics: Renal cell carcinoma treatment & Epigenetics and DNA Methylation & Prostate Cancer Treatment and Research. The author has an h-index of 29, co-authored 180 publications.
ORCID: 0000-0003-4306-4656Papers by this author
worksType 2 diabetes mellitus is associated with increased risks of sarcopenia and pre-sarcopenia in Chinese elderly
2016 · Scientific Reports · 244 citations
Prognostic value of the pretreatment systemic immune-inflammation index in patients with prostate cancer: a systematic review and meta-analysis
2023 · Journal of Translational Medicine · 116 citations
https://doi.org/10.1186/s12967-023-03924-y
Preoperative systemic immune-inflammation index predicts prognosis of patients with non-metastatic renal cell carcinoma: a propensity score-matched analysis
2020 · Cancer Cell International · 41 citations
https://doi.org/10.1186/s12935-020-01320-w
Mycotoxin exposure is associated with increased risk of esophageal squamous cell carcinoma in Huaian area, China
2019 · BMC Cancer · 38 citations
https://doi.org/10.1186/s12885-019-6439-x
Partial nephrectomy versus ablative therapies for cT1a renal masses: A Systematic Review and meta-analysis
2019 · European Journal of Surgical Oncology · 36 citations
https://doi.org/10.1016/j.ejso.2019.05.010
Diagnostic performance of metagenomic next-generation sequencing for the detection of pathogens in cerebrospinal fluid in pediatric patients with central nervous system infection: a systematic review and meta-analysis
2024 · BMC Infectious Diseases · 17 citations
https://doi.org/10.1186/s12879-024-09010-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat